PLYMOUTH, Minn., July 31 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Pat Spangler, chief financial officer, and Julie Tracy, chief communications officer are scheduled to present at the Canaccord Adams 28th Annual Global Growth Conference on Tuesday, August 12, 2008 at 4:00 p.m. Eastern Time. The Canaccord Adams 28th Annual Global Growth Conference will be held at the Intercontinental Hotel in Boston, Massachusetts.
To access the webcast, go to the investors' section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of lower extremity vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.
|SOURCE ev3 Inc.|
Copyright©2008 PR Newswire.
All rights reserved